Biotech Stocks

An uncertain future for Aurora, the first startup dedicated to custom CRISPR therapies

Endpoints News 4h ago

Aurora Therapeutics, the first company that focused on creating bespoke gene editing treatments, has laid off several staff members and stopped its lead program. The company was using CRISPR base editing to fix mutations that ...

Discussion

Sign in to join the discussion. Comments loading…